# Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE)

> **NCT04410367** · PHASE2 · COMPLETED · sponsor: **Blue Earth Diagnostics** · enrollment: 23 (actual)

## Conditions studied

- Brain Metastases

## Interventions

- **DRUG:** 18F fluciclovine

## Key facts

- **NCT ID:** NCT04410367
- **Lead sponsor:** Blue Earth Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-31
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04410367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04410367, "Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04410367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*